Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Nutex Health (NUTX) Invested Capital (2016 - 2025)

Nutex Health's Invested Capital history spans 16 years, with the latest figure at $740000.0 for Q4 2025.

  • For Q4 2025, Invested Capital fell 99.62% year-over-year to $740000.0; the TTM value through Dec 2025 reached $5.5 million, down 97.13%, while the annual FY2025 figure was $740000.0, 99.62% down from the prior year.
  • Invested Capital for Q4 2025 was $740000.0 at Nutex Health, down from $4.8 million in the prior quarter.
  • Across five years, Invested Capital topped out at $572.4 million in Q2 2022 and bottomed at $740000.0 in Q4 2025.
  • The 5-year median for Invested Capital is $157.9 million (2022), against an average of $171.1 million.
  • The largest annual shift saw Invested Capital skyrocketed 4873.86% in 2021 before it crashed 99.62% in 2025.
  • A 5-year view of Invested Capital shows it stood at $270.4 million in 2021, then crashed by 41.32% to $158.7 million in 2022, then crashed by 47.87% to $82.7 million in 2023, then skyrocketed by 133.4% to $193.0 million in 2024, then plummeted by 99.62% to $740000.0 in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Invested Capital are $740000.0 (Q4 2025), $4.8 million (Q3 2025), and $341.4 million (Q2 2025).